Pulmonary hypertension treatment cost in South Korea typically reflects a 40–60% saving compared to rates in Australia and the United States. Essential diagnostics like lab tests run from AUD $139 to AUD $417, while a specialist consultation with a pulmonologist ranges from AUD $139 to AUD $278. Total expenses depend on whether patients require medication, balloon pulmonary angioplasty, or complex surgery. Seoul and Incheon are the primary hubs for this care.
Typical Pulmonary Hypertension Treatment Costs in South Korea
Bookimed Expert Insight: For patients needing complex interventions, Asan Medical Center performs 45% of all heart transplants in South Korea with a 90% success rate. Those facing chronic clots may prefer Gangnam Severance Hospital, which performed the nation's first lung transplant. Specialist expertise is high in Incheon, where Dr. Kyung Hee Kim contributes to international clinical guidelines for pulmonary hypertension and heart failure.
No hidden fees – just official clinic prices. Pay at the clinic for Pulmonary hypertension treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pulmonary hypertension treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pulmonary hypertension treatment journey.
Dr. Kyung Hee Kim is the Director of the Heart Transplantation Center at Incheon Sejong Hospital. She serves on the American Heart Association’s Clinical Cardiology Membership Committee. This is a rare leadership role for a Korean cardiologist. Dr. Kim specializes in heart failure, transplant management, and mechanical circulatory support. She holds an MD and PhD from Seoul National University.
South Korean doctors align pulmonary hypertension care with international standards including European Society of Cardiology guidelines. While clinical practice reflects global benchmarks, doctors often use sequential therapy due to local insurance policies. Specialist centres in Seoul provide diagnosis through right heart catheterisation and multidisciplinary care.
Bookimed Expert Insight: While South Korean protocols follow international standards, local insurance often requires starting with one drug before adding others. Patients seeking immediate combination therapy should choose academic centres like Severance Hospital. These institutions partner with US leaders like Johns Hopkins. This provides earlier access to international drug protocols not yet standard in smaller Korean clinics.
Patient Consensus: Patients note that major university hospitals in Seoul are essential for this condition. Doctors there have managed hundreds of complex cases. They emphasise that while English-speaking specialists are available, patients should expect thorough testing. This includes right heart catheterisation to confirm the specific cause before starting medication.
South Korea provides most major pulmonary arterial hypertension medications found in the US and Europe. Leading Seoul hospitals stock targeted therapies like endothelin receptor antagonists and PDE5 inhibitors. Newer agents like sotatercept are now approved. Some specific intravenous prostacyclin formulations remain less common than in Western clinics.
Bookimed Expert Insight: Medications align with global standards. However, South Korea's health system often requires a monotherapy trial before approving expensive combination treatments. Dr Kyung Hee Kim trained at the Mayo Clinic. Specialists like him often lead these cases at JCI-accredited centres like Severance Hospital. The aim is for treatment to meet Western benchmarks, despite local insurance constraints.
Patient Consensus: Patients note that using generic chemical names instead of US brands helps Korean pharmacists. It helps them identify equivalent medications. Local clinics in South Korea often wait for domestic versions to clear insurance hurdles. So many suggest bringing a transition supply of newer PAH drugs.
South Korean surgeons perform pulmonary endarterectomy (PEA) at specialised tertiary centres. This complex open-heart surgery removes chronic clots from the lungs. Leading hospitals use multidisciplinary teams and deep hypothermic circulatory arrest to treat CTEPH. Surgeons often suggest balloon pulmonary angioplasty (BPA) for distal cases.
Bookimed Expert Insight: South Korea specialises in high-volume cardiac care. Seoul National University Hospital serves 30,000 international patients annually. This massive scale allows surgeons to maintain proficiency in rare procedures like PEA. Patients should look for doctors who have completed international research fellowships. Leading institutions such as the Mayo Clinic are a strong indicator. These doctors are likely familiar with the latest global protocols for CTEPH treatment.
Patient Consensus: Patients recognise Seoul as a premier destination for complex, life-saving surgeries. They frequently note the high level of digital integration in hospitals. They also mention the availability of 24/7 interpreters in Korean centres.
Private international or travel insurance typically covers pulmonary hypertension treatment in South Korea. Australian Medicare and standard private hospital cover do not pay overseas providers directly. Patients usually pay Korean hospitals upfront. They then seek reimbursement from their insurer after specialists provide the required documentation.
Bookimed Expert Insight: South Korea excels in cardiovascular care. Seoul National University Hospital serves 30,000 international cases annually. Treatment costs are 40% lower than in the US. However, some drugs are unavailable locally. Patients should confirm their medication is in stock before travelling to Seoul.
Patient Consensus: Australians should verify if their private policy covers pre-existing pulmonary hypertension or specialist overseas care. Patients in South Korea note that scans and non-routine visits often require out-of-pocket payments.